Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
MDG.WA
Strong SellSinkerMedicalgorithmics S.A. · Healthcare · Poland · $75M · Avg Vol: $219K/d
COMPANY DESCRIPTION
Medicalgorithmics S.A. develops advanced systems and algorithms for non-invasive cardiac diagnostics, centered around its proprietary PocketECG technology. The company's competitive advantage is its AI-powered ECG analysis software, which provides real-time arrhythmia detection. It operates as a high-tech medical device and software provider in the global healthcare market.
FINANCIAL SUMMARY (PLN)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 48.3M | 62.7M | 43.1M | 24.0M | 31.0M | -10.5% | 34.5M | 46.3M | 68.9M | 49.1% |
| EPS (PLN) | -39.73 | -2.08 | -0.06 | -1.62 | -1.17 | — | -0.97 | — | — | — |
| Shares | 5.0M | 10.0M | 10.0M | 10.0M | 10.0M | +100.0% | 10.0M | — | — | — |
| Debt | 9.6M | 9.0K | 0 | 4.1M | 18.9M | 18.3% | 25.6M | — | — | — |
| Equity | 47.4M | 94.7M | 92.6M | 77.2M | 64.6M | 8.1% | — | — | — | — |
| Op CF | -6.5M | 6.3M | 0.2M | -13.1M | -1.8M | -97.1% | -0.2M | — | — | — |
| Inv CF | -15.8M | -1.8M | 2.0M | -7.4M | -13.8M | — | — | — | — | — |
| Fin CF | 17.7M | 10.0M | -2.8M | 0.4M | 12.8M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of MDG.WA are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| MDG.WA | Medicalgorithmics S.A.(you) | $75M | 16 | Strong Sell |
| ICE.WA | Medinice S.A. | $200M | 25 | Sell |
| GMT.WA | Genomtec S.A. | $17M | 1 | Strong Sell |
| SNT.WA | Synektik Spólka Akcyjna | $763M | 64 | Hold |
| BCX.WA | Bioceltix S.A. | $118M | 18 | Strong Sell |
| SCP.WA | Scope Fluidics S.A. | $116M | 11 | Strong Sell |
| SVE.WA | Synthaverse S.A. | $46M | 11 | Strong Sell |
| MOC.WA | Molecure S.A. | $40M | 14 | Strong Sell |
| PTG.WA | Poltreg S.A. | $34M | 13 | Strong Sell |
| CTX.WA | Captor Therapeutics Spolka Akcyjna | $120M | 6 | Strong Sell |
Peer medians: ROE -19.0% · P/E 17.0x · Gross margin 30.1%